Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Oncology|May 22, 2013
Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non-Small Cell Lung Cancer Treated With First-line Platinum-based ChemotherapySeok-Hyun Kim, Moon Jin Kim, Yu Ji Cho, et al.
Cancers|October 29, 2020
rhEGF Treatment Improves EGFR Inhibitor-Induced Skin Barrier and Immune DefectsJi Min Kim, Jun Ho Ji, Young Saing Kim, et al.
Cancer Research and Treatment|August 19, 2009
Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysisJae-Hyuk Choi, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Journal of Breast Cancer|August 18, 2011
Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and TaxanesYu Rim Lee, Seok Jae Huh, Dong Hyun Lee, et al.
Cancer Research and Treatment|May 27, 2017
Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II StudyKi Sun Jung, Su Jin Lee, Se Hoon Park, et al.
Cancers|July 27, 2022
Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint InhibitorsHye Ryeon Kim, Jung Hun Kang, Sung Hyun Kim, et al.
BMC Cancer|May 22, 2009
Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancerDo-Kyong Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
International Journal of Hematology|June 29, 2019
The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scoresSeok Jae Huh, Sung Yong Oh, Suee Lee, et al.
The Korean Journal of Internal Medicine|March 13, 2016
Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapySeul Lee, Dong Hyun Kim, Sung Yong Oh, et al.
BMC Cancer|May 15, 2010
Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancerKyung A Kwon, Sung Hyun Kim, Sung Yong Oh, et al.
Pageof 9